Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Juan C Prieto

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
The Prostate|March 24, 2022
Tumorigenic transformation of human prostatic epithelial cell line RWPE-1 by growth hormone-releasing hormone (GHRH)Laura Muñoz-Moreno, M José Carmena, Juan C Prieto, et al.
Investigational New Drugs|July 18, 2019
Stimulation of neuroendocrine differentiation in prostate cancer cells by GHRH and its blockade by GHRH antagonistsLaura Muñoz-Moreno, María J Carmena, Andrew V Schally, et al.
Journal of Pediatric Surgery|November 21, 2007
Phenotypic expansion of the supernumerary derivative (22) chromosome syndrome: VACTERL and Hirschsprung's diseaseJuan C Prieto, Nilda M Garcia, Frederick F Elder, et al.
Proceedings of Spie--The International Society for Optical Engineering|May 22, 2018
TRAFIC: Fiber Tract Classification Using Deep LearningPrince D Ngattai Lam, Gaetan Belhomme, Jessica Ferrall, et al.
The Prostate|May 12, 2018
Growth hormone-releasing hormone receptor antagonists modify molecular machinery in the progression of prostate cancerLaura Muñoz-Moreno, Andrew V Schally, Juan C Prieto, et al.
Acta Odontologica Latinoamericana : AOL|July 22, 2010
Polymorphisms of the noggin gene and mandibular micrognathia: a first approximationSandra J Gutiérrez, Marilúz Gómez, Jorge A Rey, et al.
The Prostate|February 4, 2009
Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cellsAna B Fernández-Martínez, Ana M Bajo, Manuel Sánchez-Chapado, et al.
Bioscience Reports|October 27, 2004
Effects of the antiandrogen flutamide on the expression of protein kinase C isoenzymes in LNCaP and PC3 human prostate cancer cellsLeire Montalvo, Maria J Carmena, Oscar Bolaños, et al.
British Journal of Pharmacology|July 4, 2003
VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawalIrene Gutiérrez-Cañas, Nieves Rodríguez-Henche, Oscar Bolaños, et al.
Frontiers in Pediatrics|May 21, 2016
Sonographic Renal Parenchymal Measurements for the Evaluation and Management of Ureteropelvic Junction Obstruction in ChildrenJeremy C Kelley, Jeffrey T White, Jessica T Goetz, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
The Prostate|March 24, 2022
Tumorigenic transformation of human prostatic epithelial cell line RWPE-1 by growth hormone-releasing hormone (GHRH)Laura Muñoz-Moreno, M José Carmena, Juan C Prieto, et al.
Investigational New Drugs|July 18, 2019
Stimulation of neuroendocrine differentiation in prostate cancer cells by GHRH and its blockade by GHRH antagonistsLaura Muñoz-Moreno, María J Carmena, Andrew V Schally, et al.
Journal of Pediatric Surgery|November 21, 2007
Phenotypic expansion of the supernumerary derivative (22) chromosome syndrome: VACTERL and Hirschsprung's diseaseJuan C Prieto, Nilda M Garcia, Frederick F Elder, et al.
Proceedings of Spie--The International Society for Optical Engineering|May 22, 2018
TRAFIC: Fiber Tract Classification Using Deep LearningPrince D Ngattai Lam, Gaetan Belhomme, Jessica Ferrall, et al.
The Prostate|May 12, 2018
Growth hormone-releasing hormone receptor antagonists modify molecular machinery in the progression of prostate cancerLaura Muñoz-Moreno, Andrew V Schally, Juan C Prieto, et al.
Acta Odontologica Latinoamericana : AOL|July 22, 2010
Polymorphisms of the noggin gene and mandibular micrognathia: a first approximationSandra J Gutiérrez, Marilúz Gómez, Jorge A Rey, et al.
The Prostate|February 4, 2009
Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cellsAna B Fernández-Martínez, Ana M Bajo, Manuel Sánchez-Chapado, et al.
Bioscience Reports|October 27, 2004
Effects of the antiandrogen flutamide on the expression of protein kinase C isoenzymes in LNCaP and PC3 human prostate cancer cellsLeire Montalvo, Maria J Carmena, Oscar Bolaños, et al.
British Journal of Pharmacology|July 4, 2003
VIP and PACAP are autocrine factors that protect the androgen-independent prostate cancer cell line PC-3 from apoptosis induced by serum withdrawalIrene Gutiérrez-Cañas, Nieves Rodríguez-Henche, Oscar Bolaños, et al.
Frontiers in Pediatrics|May 21, 2016
Sonographic Renal Parenchymal Measurements for the Evaluation and Management of Ureteropelvic Junction Obstruction in ChildrenJeremy C Kelley, Jeffrey T White, Jessica T Goetz, et al.
Pageof 9